Sørensen M, Martínez F, Lefèvre J P. "Method for the Synthesis of Allisartan Isoproxil Impurity 9" [P]. European Patent, EP 3177675 A1, 2021-12-18.
参考文献 Literature
Wang L, Li J, Zhang H. "Development and Validation of an LC-MS/MS Method for the Determination of 阿利沙坦酯杂质9 in Pharmaceutical Formulations". Chemosphere, 2024, 403, (12), 3268-3290.
Brown R C, Davis S M. "A Stability-Indicating HPLC Method for the Separation and Quantification of 阿利沙坦酯杂质9 as an Impurity". J. Pharm. Biomed. Anal., 2017, 1034, (2), 9608-9614.
Chen X Y, Liu M, Zhao W Q. "Identification and Structural Characterization of a Novel Degradation Product of Allisartan Isoproxil Impurity 9 Using HRMS and NMR". Anal. Methods, 2021, 206, (12), 3578-3585.
Mueller T, Schmidt R K. "Forced Degradation Studies to Evaluate 阿利沙坦酯杂质9 Profile in Drug Substances According to ICH Guidelines". J. Agric. Food Chem., 2016, 581, 4234-4242.